CardioFocus Announces European CE Mark Approval Of The Next-Generation HeartLight Excalibur Balloon Designed For The Treatment Of Atrial Fibrillation Post author:Sam Post published:September 26, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like 3rd Stemline Patient Died in Clinical Trial One Day Before $45 Million Public Offering February 1, 2017 A Look Inside Takeda's Remarkable R&D Transformation February 26, 2017 Run by Former Genentech Employees, Bay Area's Denali Seeks $100M IPO November 13, 2017
3rd Stemline Patient Died in Clinical Trial One Day Before $45 Million Public Offering February 1, 2017